163 related articles for article (PubMed ID: 23695798)
21. Favorable response after gemcitabine-radiotherapy for invasive pancreatic intraductal papillary mucinous neoplasm: a case report.
Ochiai T; Igari K; Furuyama T; Ito H; Mitsunori Y; Aihara A; Kumagai Y; Iida M; Odajima H; Tanaka S; Arii S; Yamazaki S
Int Surg; 2013; 98(4):340-5. PubMed ID: 24229021
[TBL] [Abstract][Full Text] [Related]
22. Outcome of the pancreatic remnant following segmental pancreatectomy for non-invasive intraductal papillary mucinous neoplasm.
Miller JR; Meyer JE; Waters JA; Al-Haddad M; Dewitt J; Sherman S; Lillemoe KD; Schmidt CM
HPB (Oxford); 2011 Nov; 13(11):759-66. PubMed ID: 21999588
[TBL] [Abstract][Full Text] [Related]
23. Preoperative evaluation of invasive and noninvasive intraductal papillary-mucinous neoplasms of the pancreas: clinical, radiological, and pathological analysis of 123 cases.
Nara S; Onaya H; Hiraoka N; Shimada K; Sano T; Sakamoto Y; Esaki M; Kosuge T
Pancreas; 2009 Jan; 38(1):8-16. PubMed ID: 18665010
[TBL] [Abstract][Full Text] [Related]
24. Intraductal papillary mucinous neoplasms of the pancreas: effect of invasion and pancreatic margin status on recurrence and survival.
Raut CP; Cleary KR; Staerkel GA; Abbruzzese JL; Wolff RA; Lee JH; Vauthey JN; Lee JE; Pisters PW; Evans DB
Ann Surg Oncol; 2006 Apr; 13(4):582-94. PubMed ID: 16523362
[TBL] [Abstract][Full Text] [Related]
25. Malignant transformation of branch duct-type intraductal papillary mucinous neoplasms of the pancreas based on contrast-enhanced endoscopic ultrasonography morphological changes: focus on malignant transformation of intraductal papillary mucinous neoplasm itself.
Ohno E; Itoh A; Kawashima H; Ishikawa T; Matsubara H; Itoh Y; Nakamura Y; Hiramatsu T; Nakamura M; Miyahara R; Ohmiya N; Ishigami M; Katano Y; Goto H; Hirooka Y
Pancreas; 2012 Aug; 41(6):855-62. PubMed ID: 22481289
[TBL] [Abstract][Full Text] [Related]
26. [Surgical aspects of intraductal papillary mucinous neoplasm of the pancreas].
Oláh A
Magy Seb; 2014 Apr; 67(2):39-43. PubMed ID: 24747402
[TBL] [Abstract][Full Text] [Related]
27. Clinicopathologic study of the MIB-1 labeling index (Ki67) and postoperative prognosis for intraductal papillary mucinous neoplasms and ordinary ductal adenocarcinoma.
Takeshita A; Kimura W; Hirai I; Takasu N; Moriya T; Tezuka K; Watanabe T
Pancreas; 2012 Jan; 41(1):114-20. PubMed ID: 22143341
[TBL] [Abstract][Full Text] [Related]
28. Dysplasia at the surgical margin is associated with recurrence after resection of non-invasive intraductal papillary mucinous neoplasms.
Frankel TL; LaFemina J; Bamboat ZM; D'Angelica MI; DeMatteo RP; Fong Y; Kingham TP; Jarnagin WR; Allen PJ
HPB (Oxford); 2013 Oct; 15(10):814-21. PubMed ID: 23782351
[TBL] [Abstract][Full Text] [Related]
29. Long-term prospective cohort study of patients undergoing pancreatectomy for intraductal papillary mucinous neoplasm of the pancreas: implications for postoperative surveillance.
Kang MJ; Jang JY; Lee KB; Chang YR; Kwon W; Kim SW
Ann Surg; 2014 Aug; 260(2):356-63. PubMed ID: 24378847
[TBL] [Abstract][Full Text] [Related]
30. High-risk lesions in the remnant pancreas: fate of the remnant pancreas after pancreatic resection for pancreatic cancer and intraductal papillary mucinous neoplasms.
Miyasaka Y; Ohtsuka T; Matsuda R; Mori Y; Nakata K; Ohuchida K; Nakamura M
Surg Today; 2020 Aug; 50(8):832-840. PubMed ID: 31346809
[TBL] [Abstract][Full Text] [Related]
31. [Limited pancreatic resections for intraductal papillary mucinous neoplasm].
Blanc B; Sauvanet A; Couvelard A; Pessaux P; Dokmak S; Vullierme MP; Lévy P; Ruszniewski P; Belghiti J
J Chir (Paris); 2008; 145(6):568-78. PubMed ID: 19106888
[TBL] [Abstract][Full Text] [Related]
32. Invasive, mixed-type intraductal papillary mucinous neoplasm: superior prognosis compared to invasive main-duct intraductal papillary mucinous neoplasm.
Ceppa EP; Roch AM; Cioffi JL; Sharma N; Easler JJ; DeWitt JM; House MG; Zyromski NJ; Nakeeb A; Schmidt CM
Surgery; 2015 Oct; 158(4):937-44; discussion 944-5. PubMed ID: 26173683
[TBL] [Abstract][Full Text] [Related]
33. Significance of aggressive surgery for an invasive carcinoma derived from an intraductal papillary mucinous neoplasm diagnosed preoperatively as borderline resectable.
Aimoto T; Mizutani S; Kawano Y; Suzuki H; Uchida E
J Nippon Med Sch; 2013; 80(5):371-7. PubMed ID: 24189355
[TBL] [Abstract][Full Text] [Related]
34. Intraductal papillary mucinous neoplasms of the pancreas--predictors of malignancy.
Fan F; Lai EC; Xie F; Yang JM; Xu F; Kan T; Shen RX; Yang XY; Lau Wan Y; Wu MC
Hepatogastroenterology; 2010; 57(99-100):635-9. PubMed ID: 20698241
[TBL] [Abstract][Full Text] [Related]
35. Value of 3-T MR imaging in intraductal papillary mucinous neoplasm with a concomitant invasive carcinoma.
Sotozono H; Kanki A; Yasokawa K; Yamamoto A; Sanai H; Moriya K; Tamada T
Eur Radiol; 2022 Dec; 32(12):8276-8284. PubMed ID: 35665843
[TBL] [Abstract][Full Text] [Related]
36. The validity of the surgical indication for intraductal papillary mucinous neoplasm of the pancreas advocated by the 2017 revised International Association of Pancreatology consensus guidelines.
Watanabe Y; Endo S; Nishihara K; Ueda K; Mine M; Tamiya S; Nakano T; Tanaka M
Surg Today; 2018 Nov; 48(11):1011-1019. PubMed ID: 29961172
[TBL] [Abstract][Full Text] [Related]
37. Recurrences after surgical resection of intraductal papillary mucinous neoplasm of the pancreas: a single-center study of recurrence predictive factors.
Passot G; Lebeau R; Hervieu V; Ponchon T; Pilleul F; Adham M
Pancreas; 2012 Jan; 41(1):137-41. PubMed ID: 22076564
[TBL] [Abstract][Full Text] [Related]
38. Fate of the remnant pancreas after resection of noninvasive intraductal papillary mucinous neoplasm.
White R; D'Angelica M; Katabi N; Tang L; Klimstra D; Fong Y; Brennan M; Allen P
J Am Coll Surg; 2007 May; 204(5):987-93; discussion 993-5. PubMed ID: 17481526
[TBL] [Abstract][Full Text] [Related]
39. [Pancreatic tumor:progress in diagnosis and treatment. Topics: II. Intraductal papillary mucinous neoplasm of the pancreas (IPMN)/mucinous cystic neoplasm(MCN); 5. Management and diagnosis and therapeutic strategies for intraductal papillary mucinous neoplasm of the pancrea : IPMN].
Kimura W; Takasu N; Murayama S
Nihon Naika Gakkai Zasshi; 2012 Jan; 101(1):79-92. PubMed ID: 22413465
[No Abstract] [Full Text] [Related]
40. Clinicopathologic analysis of surgically proven intraductal papillary mucinous neoplasms of the pancreas in SNUH: a 15-year experience at a single academic institution.
Hwang DW; Jang JY; Lee SE; Lim CS; Lee KU; Kim SW
Langenbecks Arch Surg; 2012 Jan; 397(1):93-102. PubMed ID: 20640860
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]